Destiny Wealth Partners, LLC Amgen Inc Transaction History

Destiny Wealth Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $28,399 - $36,085	-124 Reduced 9.76%	1,147 $0
Q3 2022 Oct 25, 2022	BUY	$224.46 - $253.15 $69,133 - $77,970	308 Added 31.98%	1,271 $286,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $92,745 - $103,209	402 Added 71.66%	963 $234,000
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $115,555 - $127,834	527 Added 1550.0%	561 $136,000
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $7,217 - $8,455	34 New	34 $7,000
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $11,912 - $13,216	-51 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $3,772 - $4,396	17 Added 50.0%	51 $13,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $7,356 - $8,760	34 New	34 $8,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.